Recent study shows the reason for the less effective of statins motioned above may be due, at least in part, to a higher intracellular cholesterol production by hyperphosphatemia, possibly via a lower membrane LDL receptor expression (Massy et al., 2022). This evidence concerns the gene LDLR and hyperphosphatemia.